These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38180590)
21. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
22. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200 [TBL] [Abstract][Full Text] [Related]
23. Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation. Falasconi G; Gaspardone C; Godino C; Gaspardone A; Radinovic A; Pannone L; Leo G; Posteraro GA; Slavich M; Melillo F; Marzi A; D'Angelo G; Limite LR; Frontera A; Brugliera L; Agricola E; Margonato A; Della Bella P; Mazzone P Panminerva Med; 2023 Jun; 65(2):227-233. PubMed ID: 34664480 [TBL] [Abstract][Full Text] [Related]
24. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review. Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA; Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057 [TBL] [Abstract][Full Text] [Related]
25. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038 [TBL] [Abstract][Full Text] [Related]
26. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation. Black-Maier E; Piccini JP; Granger CB J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437 [TBL] [Abstract][Full Text] [Related]
27. Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens. Vignali L; Gurgoglione FL; Barocelli F; Cattabiani MA; Solinas E; Maini A; Tadonio I; Benatti G; Pelà G; Coli S; Ardissino D; Niccoli G Int J Cardiol; 2023 Jan; 371():92-99. PubMed ID: 36181948 [TBL] [Abstract][Full Text] [Related]
28. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP; JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214 [TBL] [Abstract][Full Text] [Related]
29. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion. Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447 [TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of anticoagulant monotherapy in atrial fibrillation and stable coronary artery disease: A systematic review and meta-analysis. Ullah W; Sattar Y; Shaukat M; Fischman DL Eur J Intern Med; 2020 Nov; 81():54-59. PubMed ID: 32709546 [TBL] [Abstract][Full Text] [Related]
31. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness. Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure. Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344 [TBL] [Abstract][Full Text] [Related]
33. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. Oliva A; Ioppolo AM; Chiarito M; Cremonesi A; Azzano A; Miccichè E; Mangiameli A; Ariano F; Ferrante G; Reimers B; Garot P; Amabile N; Mehran R; Condorelli G; Stefanini G; Cao D J Am Heart Assoc; 2024 Aug; 13(16):e034815. PubMed ID: 39119987 [TBL] [Abstract][Full Text] [Related]
34. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices. Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653 [TBL] [Abstract][Full Text] [Related]
35. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure. Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744 [TBL] [Abstract][Full Text] [Related]
36. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis. Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071 [TBL] [Abstract][Full Text] [Related]
37. Association between preprocedural thromboembolic and bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure. Sumiyoshi H; Fujita M; Nishiura N; Mushiake K; Chatani R; Ono S; Tasaka H; Maruo T; Kadota K; Kubo S Heart Vessels; 2024 Dec; 39(12):1045-1059. PubMed ID: 38839649 [TBL] [Abstract][Full Text] [Related]
38. Comparison of outcomes between novel oral anticoagulants and warfarin monotherapy in patients with left atrial appendage closure: A systematic review and meta-analysis. Sun B; Chen RR; Gao C; Tao L Front Cardiovasc Med; 2022; 9():1023941. PubMed ID: 36352853 [TBL] [Abstract][Full Text] [Related]
39. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry. Sedaghat A; Vij V; Al-Kassou B; Gloekler S; Galea R; Fürholz M; Meier B; Valgimigli M; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Søndergaard L; Nombela-Franco L; McInerney A; Korsholm K; Nielsen-Kudsk JE; Afzal S; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Saw J; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Rycerz S; Ognerubov D; Merkulov E; Cruz-González I; Gonzalez-Ferreiro R; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Rodes-Cabau J; Nickenig G Circ Cardiovasc Interv; 2021 May; 14(5):e010195. PubMed ID: 34003661 [TBL] [Abstract][Full Text] [Related]
40. Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysis. Turgeon RD; Ellis UM; Barry AR Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):454-464. PubMed ID: 38081213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]